Payam Soltanzadeh, MD

Dr. Payam Soltanzadeh is an Associate Clinical Professor of Neurology who specializes in neuromuscular disorders. Dr. Soltanzadeh is an expert in myotonic dystrophies types 1 and 2, inclusion body myopathies including GNE myopathy and sporadic IBM, limb-girdle muscular dystrophies (LGMDs), statin myopathies including the statin-triggered autoimmune necrotizing myopathy (HMGCR Ab+ IMNM), myositis, dystrophinopathies, myasthenia gravis, amyotrophic lateral sclerosis, and neuropathies.

Dr. Soltanzadeh received his MD from Tehran University of Medical Sciences (TUMS), where his thesis focused on hereditary inclusion body myopathy (GNE myopathy). As a Postdoctoral Fellow at the Institute of Myology, Pitié Salpêtrière Hospital in Paris (France) he conducted research on the molecular characterization of congenital myasthenic syndromes (CMS) due to MUSK mutations. Subsequently, Dr. Soltanzadeh worked with Dr. Kevin Flanigan at the University of Utah (The Eccles Institute of Human Genetics) on the United Dystrophinopathy Project, studying Genotype-phenotype correlations in Duchenne and Becker muscular dystrophies, dystrophinopathic cardiomyopathy, and manifesting carriers of Duchenne.

Dr. Soltanzadeh completed his Neurology residency at the University Of Maryland School Of Medicine in Baltimore and his Clinical Neurophysiology Fellowship (Neuromuscular Track) at the University of Utah. After finishing his fellowship, he served as a faculty staff at Cleveland Clinic Neuromuscular Center in Cleveland Ohio. He subsequently joined UCLA Department of Neurology. Dr. Soltanzadeh treats both adult and pediatric patients with neuromuscular disorders and is the Director of the UCLA EMG Laboratory.

Dr Soltanzadeh is a Diplomate of both the American Board of Psychiatry and Neurology (ABPN) and the American Board of Electrodiagnostic Medicine (ABEM).